OX40+ plasmacytoid dendritic cells in the tumor microenvironment promote antitumor immunityKate Poropatich(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Bin Zhang(Northwestern University)Journal of Clinical InvestigationMarch 17, 202010.1172/jci131992Cited by 82SaveCiteExport RISWatch citationsRelated PapersThird-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol|BMJ Open|2016|90WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability|Oncology Letters|2017|34Elemental Zn and its Binding Protein Zinc-α2-Glycoprotein are Elevated in HPV-Positive Oropharyngeal Squamous Cell Carcinoma|Scientific Reports|2019|13Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis|Research Square|2023|1